Estimate of the uncertainties in the relative risk of secondary malignant neoplasms following proton therapy and intensity-modulated photon therapy
- 12 November 2010
- journal article
- research article
- Published by IOP Publishing in Physics in Medicine & Biology
- Vol. 55 (23) , 6987-6998
Abstract
Theoretical calculations have shown that proton therapy can reduce the incidence of radiation-induced secondary malignant neoplasms (SMN) compared with photon therapy for patients with prostate cancer. However, the uncertainties associated with calculations of SMN risk had not been assessed. The objective of this study was to quantify the uncertainties in projected risks of secondary cancer following contemporary proton and photon radiotherapies for prostate cancer. We performed a rigorous propagation of errors and several sensitivity tests to estimate the uncertainty in the ratio of relative risk (RRR) due to the largest contributors to the uncertainty: the radiation weighting factor for neutrons, the dose-response model for radiation carcinogenesis and interpatient variations in absorbed dose. The interval of values for the radiation weighting factor for neutrons and the dose-response model were derived from the literature, while interpatient variations in absorbed dose were taken from actual patient data. The influence of each parameter on a baseline RRR value was quantified. Our analysis revealed that the calculated RRR was insensitive to the largest contributors to the uncertainty. Uncertainties in the radiation weighting factor for neutrons, the shape of the dose-risk model and interpatient variations in therapeutic and stray doses introduced a total uncertainty of 33% to the baseline RRR calculation.Keywords
This publication has 33 references indexed in Scilit:
- Is there a place for quantitative risk assessment?Journal of Radiological Protection, 2009
- Stray radiation dose and second cancer risk for a pediatric patient receiving craniospinal irradiation with proton beamsPhysics in Medicine & Biology, 2009
- Reducing stray radiation dose to patients receiving passively scattered proton radiotherapy for prostate cancerPhysics in Medicine & Biology, 2008
- Equivalent dose and effective dose from stray radiation during passively scattered proton radiotherapy for prostate cancerPhysics in Medicine & Biology, 2008
- Assessment of organ-specific neutron equivalent doses in proton therapy using computational whole-body age-dependent voxel phantomsPhysics in Medicine & Biology, 2008
- Secondary Carcinogenesis in Patients Treated with Radiation: A Review of Data on Radiation-Induced Cancers in Human, Non-human Primate, Canine and Rodent SubjectsRadiation Research, 2007
- Thyroid Cancer in Childhood Cancer Survivors: A Detailed Evaluation of Radiation Dose Response and its ModifiersRadiation Research, 2006
- INDICATIONS OF THE NEUTRON EFFECT CONTRIBUTION IN THE SOLID CANCER DATA OF THE A-BOMB SURVIVORSHealth Physics, 2006
- BLADDER CANCER RISK FOLLOWING PRIMARY AND ADJUVANT EXTERNAL BEAM RADIATION FOR PROSTATE CANCERJournal of Urology, 2005
- Henry S. Kaplan Distinguished Scientist Award 2003The crooked shall be made straight; dose–response relationships for carcinogenesisInternational Journal of Radiation Biology, 2004